Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
Shanghai Hile Bio-Technology Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 5/6
Shanghai Hile Bio-Technology has a total shareholder equity of CN¥1.2B and total debt of CN¥233.3M, which brings its debt-to-equity ratio to 19.3%. Its total assets and total liabilities are CN¥1.6B and CN¥394.0M respectively.
Anahtar bilgiler
19.3%
Borç/özkaynak oranı
CN¥233.25m
Borç
| Faiz karşılama oranı | n/a |
| Nakit | CN¥320.68m |
| Eşitlik | CN¥1.21b |
| Toplam yükümlülükler | CN¥394.00m |
| Toplam varlıklar | CN¥1.60b |
Son finansal sağlık güncellemeleri
Güncelleme yok
Recent updates
Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: 603718's short term assets (CN¥523.4M) exceed its short term liabilities (CN¥371.4M).
Uzun Vadeli Yükümlülükler: 603718's short term assets (CN¥523.4M) exceed its long term liabilities (CN¥22.6M).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: 603718 has more cash than its total debt.
Borcun Azaltılması: 603718's debt to equity ratio has reduced from 45.3% to 19.3% over the past 5 years.
Borç Kapsamı: 603718's debt is well covered by operating cash flow (20.4%).
Faiz Kapsamı: Insufficient data to determine if 603718's interest payments on its debt are well covered by EBIT.